665 reports of this reaction
3.9% of all PYRAZINAMIDE reports
#1 most reported adverse reaction
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is the #1 most commonly reported adverse reaction for PYRAZINAMIDE, manufactured by ANI Pharmaceuticals, Inc.. There are 665 FDA adverse event reports linking PYRAZINAMIDE to DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS. This represents approximately 3.9% of all 17,268 adverse event reports for this drug.
Patients taking PYRAZINAMIDE who experience drug reaction with eosinophilia and systemic symptoms should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is moderately reported among PYRAZINAMIDE users, representing a notable but not dominant share of adverse events.
In addition to drug reaction with eosinophilia and systemic symptoms, the following adverse reactions have been reported for PYRAZINAMIDE:
The following drugs have also been linked to drug reaction with eosinophilia and systemic symptoms in FDA adverse event reports:
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS has been reported as an adverse event in 665 FDA reports for PYRAZINAMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS accounts for approximately 3.9% of all adverse event reports for PYRAZINAMIDE, making it one of the most commonly reported side effect.
If you experience drug reaction with eosinophilia and systemic symptoms while taking PYRAZINAMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.